Wave Life Sciences Ltd. ( WVE) - Key Metrics
WVE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.34 | -$0.24 | -$0.24 |
| 2026Q1 | $0.19 | -$0.13 | -$0.30 | -$0.30 |
| 2025Q4 | $0.10 | -$0.30 | -$0.18 | -$0.18 |
| 2025Q3 | $0.05 | -$0.32 | -$0.27 | -$0.27 |
| 2025Q2 | $0.05 | -$0.31 | -$0.28 | -$0.28 |
WVE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.27 |
| 2026Q1 | 0% | -13.94 |
| 2025Q4 | 0% | -14.17 |
| 2025Q3 | 0% | -5.72 |
| 2025Q2 | 0% | -5.24 |
WVE
Price: $3.13
52 week price:
Earnings Per Share: -1.12 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Singapore
Volume: 358300
Ebitda: -26.4 millionMarket Capitalization: 697.5 million